Artificial intelligence | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Artificial intelligence articles

2025 UK MDR Regulatory Conference: Meeting report

2026-01-14T09:46:00+00:00By John Wilkinson OBE, Steve Lee and Claire McDermott

This article is a report of the 2025 UK MDR Regulatory Conference that was hosted by TOPRA and RAPS.

The evolving role of the regulatory professional in the age of Artificial Intelligence
2026-01-14T09:45:00+00:00By Peter Lassoff
Empowering digital innovation in CMC: A framework for regulatory readiness and confidence
2026-01-14T09:44:00+00:00By Dr Ian Houson, Professor Walkiria Schlindwein, Dr Chantal Mustoe and Professor Daniel Markl
Overview of the regulatory and development landscape for brain-computer interfaces in neurodegenerative disease treatment
2026-01-14T09:39:00+00:00By Zabin Younes, Maria Beatrice Panico and Tauheed Ibrahim
MD7: Updates on Artificial Intelligence legislation and policy
2025-11-18T10:07:00+00:00By Hasnaa Fatehi
MD6: The importance of digital health – Digital Health Applications (DiGA) and the Digital Mental Health Technology Project
2025-11-18T10:06:00+00:00By Steve Lee
MD5: The evolution of the EU Medical Device Regulation
2025-11-18T10:06:00+00:00By Célia Cruz

HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
2025-11-18T09:55:00+00:00By Jessica Roe
HM3: Applying Artificial Intelligence in real life
2025-11-18T09:44:00+00:00By Natasha Bankowski
HM2: Fireside chat
2025-11-18T09:44:00+00:00By Cristina Dragan
HM1: General pharmaceutical legislation - Platform technology and sandbox approaches
2025-11-18T09:44:00+00:00By Dr Evyenia Shaili
HM6: How Artificial Intelligence is transforming regulatory approaches towards chemistry, manufacturing and controls (CMC)
2025-11-13T14:35:00+00:00By Francisco Baptista
Digital transformation of global regulatory affairs: Then, now and next
2025-09-05T09:10:00+01:00By Craig Anderson and Michael J Abernathy

More AI stories